% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, AŞ Message Board

  • larry_lost_it_all larry_lost_it_all Apr 20, 2006 6:55 PM Flag



    SuperGen's Q1 loss doubles
    Thursday April 20, 6:09 pm ET

    SuperGen Thursday reported a first-quarter loss of $12.2 million, or 24 cents per share, nearly double its $6.9 million loss, or 13 cents per share, a year ago.

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • this bio and "all" micro cap bios with drugs in development trade on expecations of FDA approvals for new drugs and new compounds under development not earnings per share, as a primary factor, shithead.

      I own TTP, SNUS, and DCTH and all are micro caps with no earnings. they have doubled or more on expectations of drug and or device appprovals.

      earnings at ford- ge- or ibm are what counts for cos with on going revenues. go to there boards and bash them.

      but you are looking at earnings at supg, that would figure for a brainless fool who is wasting time on this board.